Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06847815 · ClinicalTrials.gov registry record · NA
Corn Glycemic Index
A NA study of Glycemic Index, sponsored by University of Florida.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 2
- Study locations
NCT06847815: Active NA study of Glycemic Index, sponsored by University of Florida.
NCT06847815 is a NA study of Glycemic Index that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06847815, a NA study of Glycemic Index, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
Processing sweet corn may impact digestibility and, therefore, glycemic response following consumption. The primary aim of this study is to assess the glycemic index of various sweet corn products and varieties. An exploratory aim is to assess hunger/satiety scores following sweet corn intake.
Primary Outcome
Incremental area under the glycemic response curve (iAUC)
Conditions Studied
Interventions
- OTHER Sweet corn
- OTHER Glucose Tolerance Drink
Study Locations (2)
Florida
- Food Science and Human Nutrition Building - Gainesville
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-03-05 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT06847815 still lists
NCT06847815 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Glycemic Index appearing as the primary indexed condition, and to 2 interventions - of which Sweet corn is the first listed.
NCT06847815 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06847815 about?
NCT06847815 is a clinical study titled "Corn Glycemic Index". Processing sweet corn may impact digestibility and, therefore, glycemic response following consumption. The primary aim of this study is to assess the glycemic index of various sweet corn products and varieties. An exploratory aim is to assess hunger/satiety scores following sweet corn intake.
What is the current status of trial NCT06847815?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-03-05. Estimated completion is 2025-12-31.
What conditions does trial NCT06847815 study?
This clinical trial studies the following conditions: Glycemic Index.
What interventions are being tested in trial NCT06847815?
The interventions under investigation include: Sweet corn (OTHER), Glucose Tolerance Drink (OTHER).
Who is sponsoring clinical trial NCT06847815?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06847815 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06847815's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI